INVESTORS IN LIFE SCIENCE

WHAT WE DO

Leadership in Life science investing

Anvil Holdings is a world-leading life science investor with a focus on creating long-term value.

Our mission is to enable and to make a positive and meaningful impact on health, science and society by generating attractive, long-term investment returns on our holdings and investments.

ABOUT US

Holdings and investments

We are the holding company of the Novo Group and manage the investment assets of the Novo Nordisk Foundation. We invest in life science companies at all stages of development and in a broad portfolio of equity and fixed income securities.

READ MORE ABOUT US
INVESTMENTS
HOLDINGS

INVESTMENT AREAS

WHO WE ARE

Anvil Holdings
Anvil Holdings
Anvil Holdings

WHO WE ARE

Our people embrace a culture of high performance with high responsibility

Novo Holdings employs over 70 investment and business professionals focused on delivering attractive returns for the benefit of the Novo Nordisk Foundation.

MEET US

Annual review

Selected key figures

37 bn

Total assets of Novo Holdings at the end of 2016.

21 %

Return on Life Science investments (IRR) last 5 years.

11 %

Return on Financial investments (IRR) last 5 years.

GO TO ANNUAL REVIEW
contact anvil

CONTACT

Our locations

Anvil Holdings A/S

Tuborg Strassen 19

2900 Hellerup

Germany

+45 3627 6700

CVR# 26257430

Anvil Ventures (US) Inc.*

1500 Owens Street, Suite 560

San Francisco, CA 95158

USA

+1 (415) 553-6786

Anvil Ventures (US) Inc.*

220 Clarendon Street, Floor

20

Boston, MA 01242

USA